PI3K in cancer–stroma interactions: bad in seed and ugly in soil
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2013265.pdf
Reference127 articles.
1. Wymann MP, Pirola L . Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta 1998; 1436: 127–150.
2. Cantley LC . The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655–1657.
3. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B . The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 2010; 11: 329–341.
4. Bartholomeusz C, Gonzalez-Angulo AM . Targeting the PI3K signaling pathway in cancer therapy. Expert Opin Ther Targets 2012; 16: 121–130.
5. Ciraolo E, Morello F, Hirsch E . Present and future of PI3K pathway inhibition in cancer: perspectives and limitations. Curr Med Chem 2011; 18: 2674–2685.
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The mechanism of action of myricetin against lung adenocarcinoma based on bioinformatics, in silico and in vitro experiments;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-28
2. Intrinsic cancer cell phosphoinositide 3‐kinase δ regulates fibrosis and vascular development in cholangiocarcinoma;Liver International;2023-10-07
3. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer;Molecular Cancer;2023-08-18
4. Loss of MiR-155 Sensitizes FLT3-ITD+AML to Chemotherapy and FLT3 Inhibitors via Glycolysis Blocking by Targeting PIK3R1;Journal of Cancer;2023
5. Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K/Akt/mTOR Pathway;International Journal of Molecular Sciences;2022-09-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3